Cullinan Oncology Inc
NASDAQ:CGEM
Cullinan Oncology Inc
Cash Taxes Paid
Cullinan Oncology Inc
Cash Taxes Paid Peer Comparison
Competitive Cash Taxes Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cullinan Oncology Inc
NASDAQ:CGEM
|
Cash Taxes Paid
$4.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Taxes Paid
$1.6B
|
CAGR 3-Years
101%
|
CAGR 5-Years
164%
|
CAGR 10-Years
88%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cullinan Oncology Inc's Cash Taxes Paid?
Cash Taxes Paid
4.4m
USD
Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's Cash Taxes Paid amounts to 4.4m USD.
What is Cullinan Oncology Inc's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 1Y
-88%
Over the last year, the Cash Taxes Paid growth was -88%.